Karo Pharma is a pharmaceutical company founded in 1987 specialized in sales and marketing of prescription pharmaceuticals and over-the-counter products sold in pharmacies and retail. Karo Pharma is listed on Nasdaq Stockholm Mid Cap.

Loyens & Loeff advised Karo Pharma in the transaction with a team led by Marco Toni and consisted of Fabian Sutter, Valérie Schrämli and Renate Loretan-Bührle.